Karen Knudsen/LinkedIn
May 1, 2025, 11:47
Karen Knudsen: Redefining How Parker Institute Accelerates Science to Improve Lives
Karen Knudsen, CEO of Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“The future of health is being built more quickly than ever before. But we all know that discovery alone isn’t the finish line… true impact means moving breakthroughs beyond the lab, into companies, clinics, and cures. At the Parker Institute for Cancer Immunotherapy (PICI), we are redefining what it means to accelerate science: from pioneering discoveries to startup creation, all with one goal – improving lives. That’s why the Stanford University Drug Discovery Summit is so exciting – 5,000 scientific leaders, investors, and builders coming together to turn innovation into action. Kicking off now!”
Karen Knudsen emphasized the Parker Institute’s efforts to translate scientific discoveries into real-world cancer treatments. She spotlighted the Stanford University Drug Discovery Summit as a key forum to transform research into actionable outcomes.
More posts featuring Karen Knudsen.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 8, 2025, 20:27
Jul 8, 2025, 18:55
Jul 8, 2025, 18:00